Concord Wealth Partners Dexcom Inc Transaction History

Concord Wealth Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$67.99 - $132.89 $5,099 - $9,966	-75 Reduced 70.09%	32 $2,000
Q1 2022 Apr 20, 2022	BUY	$94.08 - $130.2 $376 - $520	4 Added 3.88%	107 $55,000
Q4 2021 Jan 21, 2022	BUY	$129.87 - $162.82 $11,428 - $14,328	88 Added 586.67%	103 $55,000
Q3 2021 Nov 09, 2021	SELL	$106.71 - $143.18 $320 - $429	-3 Reduced 16.67%	15 $8,000
Q2 2021 Jul 29, 2021	BUY	$80.99 - $107.93 $1,457 - $1,942	18 New	18 $8,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.